Bone mass and the risk of prostate cancer: The Framingham Study

American Journal of Medicine

Volumn 113, Issue 9, 2002, Pages 734-739

  Zhang, Yuqing ^a   Kiel, Douglas P ^b,c   Ellison, R Curtis ^a   Schatzkin, Arthur ^e   Dorgan, Joanne F ^f   Kreger, Bernard E ^a   Cupples, L Adrienne ^d   Felson, David T ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b H Rehab Ctr Aged R Train Inst   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CALCIUM; SOMATOMEDIN C;

ADULT; ANAMNESIS; ARTICLE; BONE MASS; CANCER INCIDENCE; CANCER RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORTICAL BONE; DISEASE COURSE; DISEASE MARKER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METACARPAL BONE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIOGRAPHY;

BONE AND BONES; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; METACARPUS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 0037115516     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01382-7     Document Type: Article

References (40)

1. Hsing A.W., Tsao L., Devesa S.S. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 85:2000;60-67.
2. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J Clin. 51:2001;15-36.
3. Giovannucci E. Epidemiologic characteristics of prostate cancer. Cancer. 75:1995;1766-1777.
4. Gann P.H., Hennekens C.H., Ma J., et al. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst. 88:1996;1118-1126.
5. Dorgan J.F., Sowell A., Swanson C.A., et al. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk results from a prospective study in Columbia, Missouri (United States) . Cancer Causes Control. 9:1998;89-97.
6. Mohr B.A., Feldman H.A., Kalish L.A., et al. Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study. Urology. 57:2001;930-935.
7. Heikkila R., Aho K., Heliovaara M., et al. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma a longitudinal study . Cancer. 86:1999;312-315.
8. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk a prospective study . Science. 279:1998;563-566.
9. Harman S.M., Metter E.J., Blackman M.R., et al. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab. 85:2000;4258-4265.
10. Stattin P., Bylund A., Rinaldi S., et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk a prospective study . J Natl Cancer Inst. 92:2000;1910-1917.
11. Chan J.M., Giovannucci E.L. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev. 23:2001;87-92.
12. Hsing A.W. Hormones and prostate cancer what's next? Epidemiol Rev. 23:2001;42-58.
13. Finne P., Auvinen A., Koistinen H., et al. Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J Clin Endocrinol Metab. 85:2000;2744-2777.
14. Cutting C.W., Hunt C., Nisbet J.A., et al. Serum insulin-like growth factor-1 is not a useful marker of prostate cancer. BJU Int. 83:1999;996-999.
15. Compston J.E. Sex steroids and bone. Physiol Rev. 81:2001;419-447.
16. Mohan S., Baylink D.J. Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res. 45:(suppl 1):1996;59-62.
17. Morgan S.L. Calcium and vitamin D in osteoporosis. Rheum Dis Clin North Am. 27:2001;101-130.
18. Kreger B.E., Splansky G.L., Schatzkin A. The cancer experience in the Framingham Heart Study cohort. Cancer. 67:1991;1-6.
19. Kannel W.B., Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med. 139:1979;857-861.
20. Eaton N.E., Reeves G.K., Appleby P.N., Key T.J. Endogenous sex hormones and prostate cancer a quantitative review of prospective studies . Br J Cancer. 80:1999;930-934.
21. Wolk A., Mantzoros C.S., Andersson S.O., et al. Insulin-like growth factor 1 and prostate cancer risk a population-based, case-control study . J Natl Cancer Inst. 90:1998;911-915.
22. Schwartz G.G., Wang M.H., Zang M., et al. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 6:1997;727-732.
23. Miller G.J., Stapleton G.E., Hedlund T.E., Moffat K.A. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res. 1:1995;997-1003.
24. Pollak M. Insulin-like growth factors and prostate cancer. Epidemiol Rev. 23:2001;59-66.
25. Ross R.K., Schottenfield D. Prostate cancer. Schottenfield D., Fraumen J.F.J. Cancer Epidemiology and Prevention. 2nd ed:1996;1180-1206 Oxford University Press, New York, New York.
26. Henderson E., Bernstein L., Ross R.K., et al. The early in utero oestrogen and testosterone environment of blacks and whites potential effects on male offspring . Br J Cancer. 57:1988;216-218.
27. Ross R.K., Bernstein L., Lobo R.A., et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 339:1992;887-889.
28. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795.
29. Orwoll E.S., Klein R.F. Osteoporosis in men epidemiology, pathophysiology, and clinical characterization . Marcus R., Feldman D., Kelsey J. Osteoporosis. 1996;745-784 Academic Press, Inc, San Diego, CA.
30. Bertelloni S., Baroncelli G.I., Battini R., et al. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res. 10:1995;1488-1495.
31. Khosla S., Melton L.J. III, Atkinson E.J., O'Fallon W.M. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab. 86:2001;3555-3561.
32. Boonen S., Lesaffre E., Dequeker J., et al. Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years potential implications for the prevention of age-related bone loss . J Am Geriatr Soc. 44:1996;1301-1306.
33. Rosen C.J., Donahue L.R. Insulin-like growth factors and bone the osteoporosis connection revisited . Proc Soc Exp Biol Med. 219:1998;1-7.
34. Rosen C.J., Dimai H.P., Vereault D., et al. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone. 21:1997;217-223.
35. Kurland E.S., Rosen C.J., Cosman F., et al. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab. 82:1997;2799-2805.
36. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000;17:1-45.
37. Kroger H., Laitinen K. Bone mineral density measured by dual-energy X-ray absorptiometry in normal men. Eur J Clin Invest. 22:1992;454-460.
38. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 337:1997;670-676.
39. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr. 72:2000;745-750.
40. Kiel D.P., Hannan M.T., Broe K.E., et al. Can metacarpal cortical area predict the occurrence of hip fracture in women and men over 3 decades of follow-up? Results from the Framingham Osteoporosis Study. J Bone Miner Res. 16:2001;2260-2266.